Clinical Trials
24 trialsNCT04588246 2026-05-20
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Phase 3 Terminated
NCT04786093 2026-05-05
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT03348748 2026-04-02
Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Terminated
NCT04081688 2026-02-05
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Rutgers, The State University of New Jersey
Phase 1 Terminated
NCT03436056 2026-01-29
PRIMING
Royal Marsden NHS Foundation Trust
Phase 1 Terminated
NCT03924869 2025-12-11
KEYNOTE-867
Merck Sharp & Dohme LLC
Phase 3 Terminated
NCT03307759 2025-09-15
SABRseq
Peter MacCallum Cancer Centre, Australia
Phase 1 Terminated
NCT01217411 2024-11-19
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Terminated
NCT03050554 2024-08-09
SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
University of California, San Diego
Phase 1/2 Terminated
NCT04908956 2024-06-28
STEREO
ETOP IBCSG Partners Foundation
Phase 2 Terminated
NCT03275597 2023-05-15
Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Non-small Lung Cancer (NSCLC) With Dual Immune Checkpoint Inhibition
University of Wisconsin, Madison
Phase 1 Terminated
NCT02400814 2022-08-04
MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer
University of California, Davis
Phase 1 Terminated
NCT01799135 2021-10-12
Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)
Dana-Farber Cancer Institute
Phase NA Terminated
NCT02400424 2021-02-09
GFPC_01-14
Centre Leon Berard
Phase NA Terminated
NCT02285855 2020-01-06
Metformin in Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT02067858 2018-07-18
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPMâ„¢) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System
University of Pittsburgh
Phase NA Terminated
NCT00852644 2018-05-11
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Phase NA Terminated
NCT01188486 2018-04-17
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Stanford University
Phase NA Terminated
NCT00096265 2018-03-09
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT01511081 2017-12-07
Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01336894 2017-05-30
Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT02319889 2017-02-01
Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT01525446 2016-02-17
Proton Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer
Massachusetts General Hospital
Phase EARLY_PHASE1 Terminated
NCT01222572 2015-06-04
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Dana-Farber Cancer Institute
Phase 1/2 Terminated